Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06982196 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Sulodexide in Controlling the Recurrence of Psoriasis

StatusEnrolling by Invitation
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 21, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
Xijing Hospital
179 trials monitored
See 8 trials at risk
Psoriasis
591 trials monitored
See 24 trials at risk
This is a multicenter, randomized, double-blinded，controlled clinical trial. The purpose of the study is to evaluate the efficacy and safety of Sulodexide versus placebo in preventing psoriasis recurrence in patients with plaque psoriasis who have discontinued biologic therapy after achieving clinical cure.
Trial Details
NCT Number NCT06982196
Lead Sponsor Xijing Hospital
Conditions
(from sponsor)		 Psoriasis (PsO), Randomised Controlled Trial
Related terms Psoriasis
Enrollment 160 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov